Researchers in China have combined network-pharmacology screening with molecular-docking validation to uncover, for the first time, a shared pharmacological network that connects sensitive-skin (SS) susceptibility with post-inflammatory hyperpigmentation (PIH).  The findings provide a systematic target map for next-generation cosmeceuticals aimed at dual control of skin discomfort and uneven pigmentation. Researchers in China have combined network-pharmacology screening with molecular-docking validation to uncover, for the first time, a shared pharmacological network that connects sensitive-skin (SS) susceptibility with post-inflammatory hyperpigmentation (PIH).  The findings provide a systematic target map for next-generation cosmeceuticals aimed at dual control of skin discomfort and uneven pigmentation. 

A new study led by the International Panel on Chemical Pollution (IPCP) has investigated how corporate industries influence individuals, organisations or governments to not act in the best interest of the environment and human health.

CLEVELAND, Ohio (September 10, 2025)—Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial ovarian cancer, a new survey shows that many gynecologists and some gynecologic oncologists are still uncomfortable prescribing the therapy for this patient population. This indicates a need for more clinician education to help overcome lingering misconceptions. Results of the survey are published online today in Menopause, the journal of The Menopause Society.

New research from the Exercise Medicine Research Institute at Edith Cowan University (ECU) has highlighted that children undergoing cancer treatment often lose skeletal muscle at a time when they should be rapidly gaining it, a loss that could increase treatment complications and raise the risk of long-term health problems.